European Healthcare Acquisition & Growth Company B.V. announces change in
CEO position

EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key
word(s): Personnel
European Healthcare Acquisition & Growth Company B.V. announces change in
CEO position

02-May-2024 / 09:55 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Public disclosure of inside information according to Article 17 para. 1 of
the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)

European Healthcare Acquisition & Growth Company B.V. announces change in
CEO position

Munich, May 2, 2024

European Healthcare Acquisitions & Growth Company B.V. ("EHC") received the
resignation letter from Dr. Cornelius H. Baur as an executive director, the
chief executive officer ("CEO") and the compliance officer of EHC with
immediate effect, as he would like to pursue another supervisory board
position of a listed company. The remaining five members of EHC's board of
directors today appointed the current chief investment officer and now sole
executive director, Dr. Thomas Rudolph, also as CEO and compliance officer.
Stefan Winners, chairman of the board, Peer M. Schatz, Dr. Stefan Oschmann
and Dr. Axel Herberg remain non-executive directors of EHC.

-----------

About EHC

EHC is an operators-led special purpose acquisition company. With its
exclusive focus on healthcare, EHC is the first of its kind in Europe and
benefits from excellent investment opportunities driven by the market's
underlying fundamentals and an excellent value creation potential. In
addition, the Sponsors have created a novel structure which materially
innovates the special purpose vehicle concept to allow a very attractive
alignment of interests of all stakeholders.

Media Enquiries EHC

FGS Global

Kai Peter Rath

+49 171 861 98 06

kai.rath@fgsglobal.com

Important Notice

This release may contain forward looking statements, estimates, opinions and
projections with respect to anticipated future performance of the Company
("forward-looking statements"). These forward-looking statements can be
identified by the use of forward-looking terminology, including the terms
"believes," "estimates," "anticipates," "expects," "intends," "may," "will"
or "should" or, in each case, their negative, or other variations or
comparable terminology. These forward-looking statements include all matters
that are not historical facts. Forward-looking statements are based on the
current views, expectations and assumptions of the management of the Company
and involve significant known and unknown risks and uncertainties that could
cause actual results, performance or events to differ materially from those
expressed or implied in such statements. Forward-looking statements should
not be read as guarantees of future performance or results and will not
necessarily be accurate indications of whether or not such results will be
achieved. Any forward-looking statements included herein only speak as at
the date of this release. We undertake no obligation, and do not expect to
publicly update, or publicly revise, any of the information, forward-looking
statements or the conclusions contained herein or to reflect new events or
circumstances or to correct any inaccuracies which may become apparent
subsequent to the date hereof, whether as a result of new information,
future events or otherwise. We accept no liability whatsoever in respect of
the achievement of such forward-looking statements and assumptions.


End of Inside Information

---------------------------------------------------------------------------

02-May-2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        European Healthcare Acquisition & Growth Company B.V.
                   c/o ALR Treuhand GmbH; Theresienhöhe 28
                   80339 München
                   Germany
   ISIN:           NL0015000K10, NL0015000K28
   WKN:            A3C60V
   Listed:         Regulated Unofficial Market in Frankfurt, Munich,
                   Stuttgart; Amsterdam
   EQS News ID:    1893995

End of Announcement EQS News Service
---------------------------------------------------------------------------

1893995 02-May-2024 CET/CEST